Trial Profile
Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary) ; Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 12 Oct 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 30 Aug 2018 New trial record